AU Patent

AU2019247655A1 — Microneedle comprising silk fibroin applied to a dissolvable base

Assigned to Vaxess Technologies Inc · Expires 2020-10-01 · 6y expired

What this patent protects

Microneedle and microneedle devices including implantable silk-based tips for sustained dermal delivery of a vaccine, kits, as well as methods of manufacturing and using the same are described herein. In other embodiments, compositions and methods for controlled- or sustained- ad…

USPTO Abstract

Microneedle and microneedle devices including implantable silk-based tips for sustained dermal delivery of a vaccine, kits, as well as methods of manufacturing and using the same are described herein. In other embodiments, compositions and methods for controlled- or sustained- administration of a vaccine (e.g., an influenza vaccine) to provide improved immunogenicity and/or broad- spectrum immunity to a subject are also described.

Drugs covered by this patent

Patent Metadata

Patent number
AU2019247655A1
Jurisdiction
AU
Classification
—
Expires
2020-10-01
Drug substance claim
No
Drug product claim
No
Assignee
Vaxess Technologies Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.